R4 Vascular r4vascular.com


Vascular is driving innovation in vascular access medical technology. The company's passion is uncomplicating venous access, chemotherapy, and drug delivery. The company's product designs offer rapid exchange, Biomimetic coating, power injection ability, and associated improvements that help the company's catheters remain patent and effective. Learn more about how the company's products can improve patient care through reduced complications, while delivering lower overall costs for access and dr...Show all

Vascular is driving innovation in vascular access medical technology. The company's passion is uncomplicating venous access, chemotherapy, and drug delivery. The company's product designs offer rapid exchange, Biomimetic coating, power injection abil...Show all

Company (Alive / Active)

Phone:

Fax:

4 Willow Terrace
Hoboken, 07030
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
R4 Vascular $0M Oct 10, 2019
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related R4 Vascular Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Agentase

Pittsburgh, Pennsylvania, United States
AcquiredAgentase develops biocatalyst preparations. The company works with a variety of federal agencies and corporate clients to develop enzyme-based systems tailored to specific performance criteria. Its technology addresses the perceived limitations of enzyme catalysis such as short catalytic lifetimes that restrict product shelf life and reduce catalyst productivity, acute environmental sensitivity that limits the range of acceptable conditions for catalysis, and vulnerability to thermal denaturatio...Show allLogin to see details

Ekos

Bothell, Washington, United States
AcquiredEKOS develops clinical application of ultrasound accelerated thrombolysis for the treatment of vascular thrombosis and dissolution of thrombus.Login to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Implantable catheter port Jun 09, 2008 Dec 20, 2011 Patent
Rupture-resistant compliant radiopaque catheter balloon and methods for use of same in an intravascular surgical procedure Jul 24, 2014 Application